21:11:27 EDT Wed 24 Apr 2024
Enter Symbol
or Name
USA
CA



SEC says jurors' hockey allegiance not relevant

2014-11-12 12:53 ET - Street Wire

Also Street Wire (U-*SEC) U S Securities and Exchange Commission
Also Street Wire (U-SPPH) Spencer Pharmaceutical Inc

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Mike Caswell

With one week before the trial of Montreal's Jean-Francois Amyot begins in Boston, lawyers for the U.S. Securities and Exchange Commission have asked the judge to prevent Mr. Amyot from turning the jury selection process into a "fruitless side-show." They say Mr. Amyot, 40, has proposed several unsuitable questions for prospective jurors. Among them are a query about the lively Boston-Montreal hockey rivalry and a blunt question about any bias toward French Canadians.

The SEC says that Mr. Amyot, who is representing himself at the trial, is going beyond proper attempts at uncovering any biases a juror could have. While there is nothing wrong with inquiring about regional or ethnic issues, Mr. Amyot's question list will produce a time-consuming exercise that will achieve no results, according to the SEC. Among his questions are one in which he proposes asking the juror if he is a hockey fan and, in particular, a Boston Bruins fan. If so, Mr. Amyot proposes asking if the hockey rivalry between the Bruins and the Montreal Canadiens would influence the juror. The SEC says the question is pointless, as the trial has nothing to do with hockey. Delving into the strength of a juror's allegiance to the Boston Bruins is simply a "time-consuming, and ultimately fruitless, side-show."

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed